Revision history of "Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)" (Q35620372)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 July 2024

24 January 2024

6 April 2023

16 February 2023

9 November 2021

25 April 2021

26 May 2020

27 November 2019

20 May 2019

2 January 2019

18 November 2018

16 September 2018

12 July 2018

9 July 2018

7 April 2018

16 October 2017

8 September 2017

9 August 2017